[144] IBEX Limited SEC Filing

Rhea-AI Filing Summary

IBEX Limited reported a proposed sale of 10,000 common shares through RBC Capital Markets with an approximate aggregate market value of $300,013. The filing states the shares represent stock grants acquired on 04/20/2022 from the issuer and that the sale is expected on 08/22/2025 on NASDAQ. The filing shows 13,372,404 shares outstanding, and no other sales by the reporting person in the past three months are reported. The filer also affirms they are not aware of any undisclosed material adverse information and notes the legal warning about intentional misstatements.

Positive

• Full disclosure of the sale quantity, broker, acquisition date, and planned sale date
• Shares acquired as stock grants are identified, clarifying the source of the securities
• Attestation that the seller is not aware of undisclosed material adverse information

Negative

• None.

Insights

Securities Analyst

TL;DR Insider plans to sell a small block (≈0.075%) of shares; disclosure is routine and non-material.

The filing documents a proposed sale of 10,000 common shares valued at roughly $300,013 via a broker on NASDAQ. Given total outstanding shares of 13,372,404, the position represents about 0.075% of the float, which is immaterial to company valuation. The origin of the shares as a stock grant indicates this is likely a scheduled or opportunistic sale of vested equity rather than a company-financed transfer. The explicit representation regarding absence of undisclosed material information and the use of a broker reflect standard compliance practices.

Corporate Governance Expert

TL;DR Filing meets Rule 144 disclosure requirements; no red flags regarding timing or disclosures.

This Form 144 provides required particulars: class, broker, quantity, value, acquisition details, and planned sale date. The shares were acquired via a stock grant from the issuer on 04/20/2022, and no recent sales are reported, reducing concerns about repeated insider dispositions. The signer’s attestation about material information and the included broker details align with best practice for transparency. There is no indication of undisclosed arrangements or unusual payment terms.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RBC CAPITAL MARKETS LLC 250 Nicollet Mall Suite 1700 Minneapolis MN 55401	10000	300013.00	13372404	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	04/20/2022	STOCK GRANT	ISSUER			10000	04/20/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being reported in the IBEX (IBEX) Form 144?

The filing reports a proposed sale of 10,000 common shares via RBC Capital Markets with aggregate market value $300,013 and an expected sale date of 08/22/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired as a stock grant from the issuer on 04/20/2022.

What percentage of outstanding shares does this sale represent for IBEX?

The filing lists 13,372,404 shares outstanding; 10,000 shares represent about 0.075% of that total.

Was the filer reported to have sold any IBEX securities in the past three months?

The filing indicates Nothing to Report for securities sold during the past three months by the reporting person.

On which exchange is the proposed sale expected to occur?

The proposed sale is expected to occur on NASDAQ via RBC Capital Markets.